Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07235384RecruitingPhase 1
Zai Lab tests ZL-1503 for moderate to severe eczema
This study tests a new medication called ZL-1503 for people with moderate to severe atopic dermatitis (eczema) that hasn't improved enough with topical treatments. The trial will check if the drug is safe and how well it works.
Woolloongabba, QueenslandAges 18–65 - NCT07230496RecruitingPhase 1
Safety study of an investigational weight-management drug
This study is testing a new investigational drug, either alone or combined with another drug, to see how safe it is and how the body processes it. It is for healthy people who are overweight or obese, and results may help in developing future treatments for weight management.
Sydney, New South WalesAges 18–75 - NCT07231679RecruitingPhase 1/Phase 2
Study of IGT-303 for diabetic kidney disease
This study tests an investigational drug called IGT-303 in people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and helpful for slowing kidney damage.
Chula Vista, CaliforniaAges 18–75 - NCT07237425RecruitingPhase 1
Injectable treatment for fatty lumps (lipomas)
This study tests an injectable drug (Ronkyla Plus) for shrinking fatty lumps (lipomas). It may be a good option if you have one or more lipomas that have not changed in size for at least 6 months.
Taipei, Da'an DistrictAges 18–65 - NCT07231419RecruitingPhase 3
Study of suzetrigine for diabetic nerve pain
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Birmingham, AlabamaAges 18–80 - NCT07230730RecruitingPhase 3
Study of an investigational add-on treatment for high cholesterol
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
Hangzhou, ZhejiangAges 18 years+ - NCT07239336RecruitingPhase 2
Study of DONQ52 for active celiac disease
This trial tests a new drug called DONQ52 in people with active celiac disease who still have symptoms despite following a gluten-free diet. The goal is to see if DONQ52 can help reduce damage to the small intestine and improve gluten-related symptoms.
Anniston, AlabamaAges 18–75 - NCT07234591Recruiting
Study of an oral medication for moderate to severe plaque psoriasis
This study tests an experimental oral medication (a TYK2 inhibitor) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing psoriasis symptoms.
ShanghaiAges 18–70 - NCT07235917RecruitingPhase 2
Mibavademab for functional hypothalamic amenorrhea
This trial tests an investigational drug called mibavademab for women whose periods have stopped due to a condition called functional hypothalamic amenorrhea (FHA). It may help restart your menstrual cycle by targeting hormones involved in reproduction.
Phoenix, ArizonaAges 18–40 - NCT07238478Recruiting
Supplement for menopause quality of life in postmenopausal women
This trial tests a dietary supplement to see if it can improve menopause-related symptoms, like hot flashes and joint discomfort, in healthy postmenopausal women.
Harrison, New YorkAges 50–70 - NCT07235059RecruitingPhase 1
Testing OJR520 in healthy people and those with chronic kidney disease
This study tests a new drug called OJR520 to see if it's safe and how the body processes it. It first tests healthy volunteers and then people with chronic kidney disease to understand the drug's effects.
Miami, FloridaAges 18–65 - NCT06247046RecruitingPhase 3
Probiotic powder for IBS-D (SK08) trial
This study tests a new probiotic powder (SK08) to see if it reduces belly pain and diarrhea in people with IBS-D (irritable bowel syndrome with diarrhea). It lasts several months and involves taking the study powder twice a day.
Wuxi, JiangsuAges 18–70 - NCT07231484Recruiting
Grape study for immune and gut health in obesity
This trial tests if eating grapes every day for 4 weeks can improve your immune system and gut health. It is designed for adults with obesity who are willing to keep their diet and activity stable during the study.
Columbia, MissouriAges 18–60 - NCT07233707Enrolling by invitation
Creatine loading and breath-hold cycling performance
This study tests whether taking creatine monohydrate for 7 days improves how long you can hold your breath while cycling. It's for healthy, experienced breath-hold divers who haven't used creatine recently.
Athens, KallitheaAges 18 years+ - NCT07239791Recruiting
Does a low-dose medication affect how we learn?
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
ParisAges 18–39 - NCT07234695RecruitingPhase 3
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's
This trial tests if levetiracetam, a seizure medication, can prevent seizures in adults with Down syndrome who also have Alzheimer's disease. It aims to help manage a common complication and improve quality of life.
Granada, AndalusiaAges 40 years+ - NCT07236788Recruiting
Iron infusion to prevent anemia and improve life in obese patients
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
BeijingAges 18–65 - NCT07235228Recruiting
Synbiotic supplement for irritable bowel syndrome
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
JarocinAges 18–65 - NCT07234916Enrolling by invitation
Multivitamins for people starting weight-loss injections
This trial tests whether a multivitamin can help people on the weight-loss injection Tirzepatide maintain healthy vitamin levels. If you're using this injection and meet the other criteria, you may join.
AmersfoortAges 18–70 - NCT07234422RecruitingPhase 3
Selenium and CoQ10 for heart failure
This study tests whether adding selenium and CoQ10 (two natural supplements) to standard heart failure treatment helps people with chronic heart failure feel better and improve their health. Researchers are using a registry-based approach to track participants in the Netherlands.
AlkmaarAges 18 years+ - NCT07239115RecruitingPhase 3
Levetiracetam to prevent seizures after brain tumor surgery
This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.
BeijingAges 18–75 - NCT07232069RecruitingPhase 3
Early heart disease trial for women and men with mild plaque buildup
This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.
Birmingham, AlabamaAges 30–60 - NCT07235215Recruiting
Testing Vivatlac for Irritable Bowel Syndrome
This study tests a product called Vivatlac to see if it can help people with Irritable Bowel Syndrome (IBS). If you have moderate-to-severe IBS and haven't taken probiotics or antibiotics recently, you may be able to join.
JarocinAges 18–65 - NCT07234890RecruitingPhase 2
Testing AV-001 to protect the brain during hemodialysis
This study tests a new medicine called AV-001 to see if it can protect the brain from damage caused by hemodialysis. If you qualify, you may help find a way to reduce thinking and memory problems linked to dialysis.
London, OntarioAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.